Expert Review of Neurotherapeutics

Papers
(The H4-Index of Expert Review of Neurotherapeutics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system52
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease51
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives46
Therapeutic advances in Dravet syndrome: a targeted literature review44
Manganese-induced neurodegenerative diseases and possible therapeutic approaches36
Update on diagnosis in disorders of consciousness34
Clinical diagnosis and management of small fiber neuropathy: an update on best practice33
Diagnosing and managing post-stroke aphasia33
The emerging role of psilocybin and MDMA in the treatment of mental illness29
Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice29
A systematic review of morbidities suggestive of the multiple sclerosis prodrome28
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy28
Sex differences in schizophrenia relevant to clinical care27
The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders27
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies27
Focal cortical dysplasia: an update on diagnosis and treatment26
Nutrition-based interventions for mood disorders25
Role of environmental factors in multiple sclerosis24
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults23
What is the potential of neurostimulation in the treatment of motor symptoms in schizophrenia?23
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis22
Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review21
Emerging therapies in Friedreich’s Ataxia21
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome21
0.040005922317505